Cargando…

Biosynthesis of Galactan in Mycobacterium tuberculosis as a Viable TB Drug Target?

While target-based drug design has proved successful in several therapeutic areas, this approach has not yet provided compelling outcomes in the field of antibacterial agents. This statement remains especially true for the development of novel therapeutic interventions against tuberculosis, an infec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Konyariková, Zuzana, Savková, Karin, Kozmon, Stanislav, Mikušová, Katarína
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168186/ https://www.ncbi.nlm.nih.gov/pubmed/31935842 http://dx.doi.org/10.3390/antibiotics9010020

Ejemplares similares

Synthesis, docking study and biological evaluation of ᴅ-fructofuranosyl and ᴅ-tagatofuranosyl sulfones as potential inhibitors of the mycobacterial galactan synthesis targeting the galactofuranosyltransferase GlfT2
por: Baráth, Marek, et al.
Publicado: (2020)

Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure
por: Ambreen, Atiqa, et al.
Publicado: (2019)

Galactan-binding antibodies. Diversity and structure of idiotypes
Publicado: (1983)

TB or not TB? Mycobacterium celatum mimicking Mycobacterium tuberculosis: A case of mistaken identity
por: Chavarria, Michael, et al.
Publicado: (2018)

Drug Susceptibility of Mycobacterium tuberculosis Beijing Genotype and Association with MDR TB
por: de Steenwinkel, Jurriaan E.M., et al.
Publicado: (2012)

Novel arabinan and galactan oligosaccharides from dicotyledonous plants
por: Wefers, Daniel, et al.
Publicado: (2014)

Identification of d-Galactan-III As Part of the Lipopolysaccharide of Klebsiella pneumoniae Serotype O1
por: Stojkovic, Katarina, et al.
Publicado: (2017)

A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK
por: Chiarelli, Laurent R., et al.
Publicado: (2018)

RNA Sensing of Mycobacterium tuberculosis and Its Impact on TB Vaccination Strategies
por: Burkert, Sanne, et al.
Publicado: (2020)

Is Receptor-Interacting Protein Kinase 3 a Viable Therapeutic Target for Mycobacterium tuberculosis Infection?
por: Stutz, Michael D., et al.
Publicado: (2018)

Galactan synthesis in a single step via oligomerization of monosaccharides
por: Dräger, Marius, et al.
Publicado: (2014)

Feasibility of novel approaches to detect viable Mycobacterium tuberculosis within the spectrum of the tuberculosis disease
por: Alebouyeh, Sogol, et al.
Publicado: (2022)

Identification of Inhibitors against Mycobacterium tuberculosis Thiamin Phosphate Synthase, an Important Target for the Development of Anti-TB Drugs
por: Khare, Garima, et al.
Publicado: (2011)

Structure of Mycobacterium tuberculosis cytochrome bcc in complex with Q203 and TB47, two anti-TB drug candidates
por: Zhou, Shan, et al.
Publicado: (2021)

Bioinformatics Analysis to Uncover the Potential Drug Targets Responsible for Mycobacterium tuberculosis Peptidoglycan and Lysine Biosynthesis
por: Ayu Eka Pitaloka, Dian, et al.
Publicado: (2023)

Cell wall peptidoglycan in Mycobacterium tuberculosis: An Achilles’ heel for the TB-causing pathogen
por: Maitra, Arundhati, et al.
Publicado: (2019)

Asiaticoside A for the modulation of 1-TbAd- a potential target and ligand for extensive drug resistance Mycobacterium tuberculosis
por: Tilwani, Komal, et al.
Publicado: (2023)

Surface Anchoring of the Kingella kingae Galactan Is Dependent on the Lipopolysaccharide O-Antigen
por: Montoya, Nina R., et al.
Publicado: (2022)

Fragment-Based Design of Mycobacterium tuberculosis InhA Inhibitors
por: Sabbah, Mohamad, et al.
Publicado: (2020)

Culture-free proof of Mycobacterium tuberculosis - a new assay for viable bacteria
por: Heyckendorf, Jan, et al.
Publicado: (2020)

Molecular Modeling Insights into the Structure and Behavior of Integrins: A Review
por: Tvaroška, Igor, et al.
Publicado: (2023)

Mycobacterium tuberculosis-specific cytokine biomarkers for the diagnosis of childhood TB in a TB-endemic setting
por: Sudbury, Eva L., et al.
Publicado: (2019)

PolyTB: A genomic variation map for Mycobacterium tuberculosis
por: Coll, Francesc, et al.
Publicado: (2014)

QIAreach QuantiFERON-TB for the diagnosis of Mycobacterium tuberculosis infection
por: Saluzzo, Francesca, et al.
Publicado: (2022)

Correction to Fragment-Based Design of Mycobacterium tuberculosis InhA Inhibitors
por: Sabbah, Mohamad, et al.
Publicado: (2020)

Mycobacterium tuberculosis Shikimate Pathway Enzymes as Targets for the Rational Design of Anti-Tuberculosis Drugs
por: Nunes, José E. S., et al.
Publicado: (2020)

S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope
por: Singh, Padam, et al.
Publicado: (2017)

Biosynthesis and Translocation of Unsulfated Acyltrehaloses in Mycobacterium tuberculosis
por: Belardinelli, Juan Manuel, et al.
Publicado: (2014)

Effect of red seaweed sulfated galactans on initial steps of complement activation in vitro
por: Sokolova, E.V., et al.
Publicado: (2021)

Structural Diversity in Galactans From Red Seaweeds and Its Influence on Rheological Properties
por: Ciancia, Marina, et al.
Publicado: (2020)

Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial Activity
por: Fan, Dongguang, et al.
Publicado: (2023)

Determination of the activity of standard anti-tuberculosis drugs against intramacrophage Mycobacterium tuberculosis, in vitro: MGIT 960 as a viable alternative for BACTEC 460
por: Jhamb, Sarbjit Singh, et al.
Publicado: (2014)

Inhibition of Glutamine Synthetase: A Potential Drug Target in Mycobacterium tuberculosis
por: Mowbray, Sherry L., et al.
Publicado: (2014)

Resistance to First-Line Anti-TB Drugs Is Associated with Reduced Nitric Oxide Susceptibility in Mycobacterium tuberculosis
por: Idh, Jonna, et al.
Publicado: (2012)

Drug Resistance Pattern of Mycobacterium tuberculosis Isolates From Patients Referred to TB Reference Laboratory in Ahvaz
por: Badie, Fereshteh, et al.
Publicado: (2016)

TB-ML—a framework for comparing machine learning approaches to predict drug resistance of Mycobacterium tuberculosis
por: Libiseller-Egger, Julian, et al.
Publicado: (2023)

Drug Resistance Mechanisms in Mycobacterium tuberculosis
por: Palomino, Juan Carlos, et al.
Publicado: (2014)

The COMBAT-TB Workbench: Making Powerful Mycobacterium tuberculosis Bioinformatics Accessible
por: van Heusden, Peter, et al.
Publicado: (2022)

Correction to “S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope”
por: Singh, Padam, et al.
Publicado: (2017)

Plant Xyloglucan Xyloglucosyl Transferases and the Cell Wall Structure: Subtle but Significant
por: Stratilová, Barbora, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p2j4vu7fo4gbi5poqa3juphk23